Data Dictionary

Data Dictionary
Code Display Definition
no Not accumulated No contrast accumulated
less10-13 Less Than 10-30HU Less Than 10-30HU of contrast accumulated
more30 More Than 30HU More Than 30HU of contrast accumulated
Code Display Definition
upper Upper Lobus Affect localized in Upper Lobus
upperAndMedium Upper and Medium Lobbi Affect localized in Upper and Medium Lobbi
upperAndLower Upper and Lower Lobbi Affect localized in Upper and Lower Lobbi
medium Medium Lobus Affect localized in Medium Lobus
lower Lower Lobus Affect localized in Lower Lobus
mediumAndLower Medium and Lower Lobbi Affect localized in Medium and Lower Lobbi
total Total lung affected Total lung affected
Code Display Definition
Glukoza Glucose (mmol/l) Glucose (mmol/l)
GlukozaDiabetic Glucose: Diabetic Post-Meal (mmol/l) Glucose: Diabetic Post-Meal (mmol/l)
Total Protein Total Protein (g/l) Total Protein (g/l)
Albumin Albumin (g/l) Albumin (g/l)
Urea Urea (mmol/l) Urea (mmol/l)
Kreatinini Creatinine (µmol/l) Creatinine (µmol/l)
HBsAg Hepatitis B Surface Antigen Hepatitis B Surface Antigen
HCV Hepatitis C Virus Hepatitis C Virus
Na+ Sodium (mmol/l) Sodium (mmol/l)
Ca 2+ Calcium (mmol/l) Calcium (mmol/l)
K+ Potassium (mmol/l) Potassium (mmol/l)
ALP Alkaline phosphatase (u/l) Alkaline phosphatase (u/l)
GGT Gamma-Glutamyl Transpeptidase (u/l) Gamma-Glutamyl Transpeptidase (u/l)
AST Aspartate Aminotransferase (u/l) Aspartate Aminotransferase (u/l)
ALT Alanine Aminotransferase (u/l) Alanine Aminotransferase (u/l)
Total Bilirubin Total Bilirubin (µmol/l) Total Bilirubin (µmol/l)
ADA Adenosine Deaminase (u/l) Adenosine Deaminase (u/l)
APTT Activated Partial Thromboplastin Time (seconds) Activated Partial Thromboplastin Time (seconds)
TT Thrombin Time (seconds) Thrombin Time (seconds)
Pt Prothrombin Time (%) Prothrombin Time (%)
INR International Normalized Ratio International Normalized Ratio
Lipaza Lipase (u/l) Lipase (u/l)
TSH Thyroid Stimulating Hormone (miu/l) Thyroid Stimulating Hormone (miu/l)
FT4 Free Thyroxine (ng/dl) Free Thyroxine (ng/dl)
Code Display Definition
hiv HIV HIV/AIDS (Human immunodeficiency virus / Acquired immunodeficiency syndrome)
diabets Diabetes Diabetes mellitus (DM)
hepaticDiseases Hepatic diseases Liver diseases
renalDisease Renal disease Renal disease
anemia Anemia Anemia
none None None
notSpecified Not specified Not specified
others Others Other comorbidities
Code Display Definition
no Not used Contrast not used
0407-1413-10 OMNIPAQUE 350 OMNIPAQUE 350 is used as contrast
Code Display Definition
liquid Liquid Liquid
solid Solid Solid
notSpecified Not specified Not specified
Code Display Definition
good Good image quality Good image quality
average Average image quality Average image quality
poor Poor image quality Poor image quality
Code Display Definition
new New New patients have never been treated for TB or have taken anti-TB drugs for less than 1 month
relapse Relapse Relapse patients have previously been treated for TB, were declared cured or treatment completed at the end of the most recent course of treatment, and are now diagnosed with a recurrent episode of TB (either a true relapse or a new episode of TB caused by reinfection)
ltfu Lost to follow up Treatment after loss to follow-up patients have previously been treated for TB and were declared lost to follow-up at the end of their most recent course of treatment. (These were previously known as treatment after default patients.)
failure Failure Treatment after failure patients are those who have previously been treated for TB and whose treatment failed at the end of the most recent course of treatment
other Other Other previously treated patients are those who have previously been treated for TB but whose outcome after the most recent course of treatment is unknown or undocumented
unknown Unknown Unknown case definition
Code Display Definition
H Isoniazid Isoniazid (H, INH)
R Rifampicin Rifampicin (R, RIF)
S Streptomycin Streptomycin (S)
E Ethambutol Ethambutol (E, EMB)
Ofx Ofloxacin Ofloxacin (Ofx)
Cm Capreomycin Capreomycin (Cm)
Am Amikacin Amikacin (Am)
Km Kanamycin Kanamycin (Km)
Z Pyrazinamide Pyrazinamide (Z, PZA)
Lfx Levofloxacin Levofloxacin (Lfx)
Mfx Moxifloxacin Moxifloxacin (Mfx)
Mfx 0.25 Moxifloxacin 0.25 Moxifloxacin 0.25 (Mfx 0.25)
Mfx 1.0 Moxifloxacin 1.0 Moxifloxacin 1.0 (Mfx 1.0)
Pas p-aminosalicylic acid p-aminosalicylic acid (Pas, PAS)
Pto Prothionamide Prothionamide (Pto)
Cs Cycloserine Cycloserine (Cs)
Amx/Clv Amoxicillin-clavulanate Amoxicillin-clavulanate (Amx/Clv)
Mb Mycobutin Mycobutin (Mb)
Eto Ethionamide Ethionamide (Eto)
Dld Delamanid Delamanid (Dlm)
Bdq Bedaquiline Bedaquiline (Bdq)
Ipm/Cln Imipenem-cilastatin Imipenem-cilastatin (Ipm/Cln)
Lzd Linezolid Linezolid (Lzd)
Cfz Clofazimine Clofazimine (Cfz)
Clr Clarithromycin Clarithromycin (Clr)
Ft Fluoroquinolones Fluoroquinolones (Ofx, Lfx or Mfx )
AG/CP Aminoglycosides - injectible agents Aminoglycosides - injectible agents (Cm, Km, Am)
Code Display Definition
R R (Resistant) R (Resistant)
S S (Sensitive) S (Sensitive)
I I (Intermediate) I (Intermediate)
Code Display Definition
basicSchool Basic school (incl. primary) Basic scool: providing instruction in reading, writing and mathematics; the formation of ideas about man and the world, labor skills
completeSchool Complete school (a-level, gymnasium) Complete scool: aimed at preparing him for a full life in society, students master the fundamentals of science, the state languages of the Republic of Belarus, skills, mental and physical labor, ready to begin work and further education
college College (bachelor) College: aimed at the development of the individual student, trainee, they receive a special theoretical and practical training, culminating in qualification specialists with secondary special education, working with secondary special education
higher Higher (university) Higher Education: to provide a special theoretical and practical training, culminating in qualification of specialists with higher education, a master's degree
noEducation No education No education, or basic scool in progress
Code Display Definition
pulm Pulmonary Pulmonary tuberculosis (PTB) refers to any bacteriologically confirmed or clinically diagnosed case of TB involving the lung parenchyma or the tracheobronchial tree. Miliary TB is classified as PTB because there are lesions in the lungs. Tuberculous intra - thoracic lymphadenopathy(mediastinal and / or hilar) or tuberculous pleural effusion, without radiographic abnormalities in the lungs, constitutes a case of extrapulmonary TB
extraPulm Extrapulmonary Extrapulmonary tuberculosis (EPTB) refers to any bacteriologically confirmed or clinically diagnosed case of TB involving organs other than the lungs, e.g. pleura, lymph nodes, abdomen, genitourinary tract, skin, joints and bones, meninges
both Pulmonary and Extrapulmonary Pulmonary tuberculosis(PTB) and extrapulmonary TB(EPTB) diagnosed at the same time
unknown Unknown Unknown
Code Display Definition
-0.09 1 to 9 in 100 (1-9/100) 1 to 9 acid-resistant bacteria in 100 fields of view (1-9/100)
1+ 10 to 99 in 100 (1+) 10 to 99 acid-resistant bacteria in 100 fields of view (1+)
2+ 1 to 9 in 1 (2+) 1 to 9 acid-resistant bacteria in 1 fields of view (2+)
3+ 10 to 99 in 1 (3+) 10 to 99 acid-resistant bacteria in 1 fields of view (3+)
4+ More than 99 in 1 (4+) All fields of view (4+)
saliva Saliva Saliva sample for the study is not suitable
unknownData Unknown data No data
negative Negative Negative result
notDone Not done Not done
Code Display Definition
CR CR (Computed Radiography) CR (Computed Radiography)
CT CT (Computed Tomography) CT (Computed Tomography)
XC XC (External-camera Photography) XC (External-camera Photography)
XA XA (X-Ray Angiography) XA (X-Ray Angiography)
Code Display Definition
stillOnTreatment Still on treatment A patient who is still undergoing treatment
died Died A patient who dies for any reason during the course of treatment
cured Cured Treatment completed as recommended by the national policy without evidence of failure AND three or more consecutive cultures taken at least 30 days apart are negative after the intensive phase
completed Completed Treatment completed as recommended by the national policy without evidence of failure BUT no record that three or more consecutive cultures taken at least 30 days apart are negative after the intensive phase
ltfu Lost to follow up Treatment after loss to follow-up patients have previously been treated for TB and were declared lost to follow-up at the end of their most recent course of treatment. (These were previously known as treatment after default patients.)
unknown Unknown A patient for whom no treatment outcome is assigned. (This includes cases transferred out to another treatment unit and whose treatment outcome is unknown)
failure Failure Treatment terminated or need for permanent regimen change of at least two anti - TB drugs because of: a lack of conversion by the end of the intensive phase, or a bacteriological reversion in the continuation phase after conversion to negative, or a evidence of additional acquired resistance to fluoroquinolones or second - line injectable drugs, or a adverse drug reactions (ADRs)
Code Display Definition
H Isoniazid Isoniazid (H, INH)
R Rifampicin Rifampicin (R, RIF)
S Streptomycin Streptomycin (S)
E Ethambutol Ethambutol (E, EMB)
Ofx Ofloxacin Ofloxacin (Ofx)
Cm Capreomycin Capreomycin (Cm)
Am Amikacin Amikacin (Am)
Km Kanamycin Kanamycin (Km)
Z Pyrazinamide Pyrazinamide (Z, PZA)
Lfx Levofloxacin Levofloxacin (Lfx)
Mfx Moxifloxacin Moxifloxacin (Mfx)
Pas p-aminosalicylic acid p-aminosalicylic acid (Pas)
Pto Prothionamide Prothionamide (Pto)
Cs Cycloserine Cycloserine (Cs)
Amx/Clv Amoxicillin-clavulanate Amoxicillin-clavulanate (Amx/Clv)
Mb Mycobutin Mycobutin (Mb)
Eto Ethionamide Ethionamide (Eto)
Dld Delamanid Delamanid (Dlm)
Bdq Bedaquiline Bedaquiline (Bdq)
Ipm/Cln Imipenem-cilastatin Imipenem-cilastatin (Ipm/Cln)
Lzd Linezolid Linezolid (Lzd)
Cfz Clofazimine Clofazimine (Cfz)
Clr Clarithromycin Clarithromycin (Clr)
Ft Fluoroquinolones Fluoroquinolones (Fq)
AG/CP Aminoglycosides - injectible agents Aminoglycosides - injectible agents (Cm, Km, Am)
Trd Terizidone Terizidone (Trd)
ART Antiretroviral therapy Antiretroviral therapy (ART) is treatment of people infected with human immunodeficiency virus (HIV) using anti-HIV drugs
Cotrimoxazol Cotrimoxazol preventive Co-trimoxazole preventive therapy (CPT)
Code Display Definition
focal Nodule less than 10mm Nodule less than 10mm
focus Node more than 10mm Node more than 10mm
focalFocus Nodule and node Both Nodule <10mm and Node >10mm
infiltrate Infiltrate(s) Localised alveoloacinar diseases
focalFocusInfiltrate Nodule, node and infiltrate Nodule <10mm, Node >10mm and Infiltrate together
Code Display Definition
ended Treatment ended Treatment ended (for current treatment regimen)
adverse Adverse event Adverse event documented (treatment stopped for current treatment regimen)
resistance Treatment ineffective due to additional resistance Additional resistance discovered, treatment regimen is not effctive (treatment stopped for current treatment regimen)
continuation Continuation of treatment Continuation of treatment (for current treatment regimen)
newDrugAvailable New drugs available New drugs available (for current treatment regimen)
patientStoppedTreatment Patient stopped treatment Patient stopped treatment (for current treatment regimen)
terminated Terminated from study Terminated from study (for current treatment regime)
Code Display Definition
male Male Male
female Female Female
other Other Other
unknown Unknown Unknown
Code Display Definition
S1 S1 Affected segment S1
S1+2 S1+2 Affected segment S1 + 2
S1-3 S1-3 Affected segment S1-3
S2 S2 Affected segment S2
S2+3 S2+3 Affected segment S2 + 3
S3 S3 Affected segment S3
S4 S4 Affected segment S4
S5 S5 Affected segment S5
S4+5 S4+5 Affected segment S4 - 5
S1-5 S1-5 Affected segment S1-5
S6 S6 Affected segment S6
S1-6 S1-6 Affected segment S1-6
S7-10 S7-10 Affected segment S7-10
Total All segments Affected all segments
Code Display Definition
biopsy Biopsy Biopsy sample for TB diagnostic is used
sputum Sputum Sputum sample for TB diagnostic is used
other Other Other sample for TB diagnostic is used
surgeryCaseousMasses Surgery-caseous masses Masses which are in a cavity or in other TB lesions of lungs (tuberculoma, large nodi or conglomerate of the nodi)
surgeryCavityInternalWall Surgery-cavity internal wall Internal wall of a cavity
surgeryCavityExternalWall Surgery-cavity external wall External wall of a cavity
surgeryModulu Surgery-infectious granuloma Infectious granulomas (which are formed by cells as a reaction to a tuberculosis infection)
surgeryHealthy tissue Surgery-healthy tissue The lung tissue not damaged by tubercular process
bronchialLavage Bronchial lavage The liquid received at a bronchial lavage during a bronchoscopy
asciticFluid Ascitic fluid Liquid gathered in an abdominal cavity at various pathological states
blood Blood Blood
Code Display Definition
preliminary Preliminary This is a preliminary composition or document (also known as initial or interim). The content may be incomplete or unverified
final Final This version of the composition is complete and verified by an appropriate person and no further work is planned. Any subsequent updates would be on a new version of the composition
amended Amended The composition content or the referenced resources have been modified (edited or added to) subsequent to being released as "final" and the composition is complete and verified by an authorized person
retracted Retracted The composition was originally created/issued in error and this is an amendment that marks that the entire composition and any past versions or copies should not be considered as valid
Code Display Definition
singleColony 1 to 19 1 to 19 colonies (Single Colony)
1+ 20 to 100 20 to 100 colonies (1+)
2+ 100 to 200 100 to 200 colonies (2+)
3+ More than 200 More than 200 colonies (3+)
positive Positive Growth of mycobacterium (Positive)
negative Negative At the end of the study protocol growth is not fixed (Negative)
unknownData Unknown result Result not entered
unfinishedResult Study in progress Continuing the study (in progress)
notDone Not done Not done
contamination Nonspecific microflora The appearance of nonspecific microflora growth alone or together with mycobacteria
mott MOTT Mycobacterium other than tuberculosis (MOTT)
Code Display Definition
upperLeft Upper Left Sextant Upper Left Sextant
upperRight Upper Right Sextant Upper Right Sextant
midLeft Middle Left Sextant Middle Left Sextant
midRight Middle Right Sextant Middle Right Sextant
lowerLeft Lower Left Sextant Lower Left Sextant
lowerRight Lower Right Sextant Lower Right Sextant
Code Display Definition
practitioner General practitioner General practitioner
radiologist Radiologist Radiologist
other Other Other
Code Display Definition
A15 A15 A15 - Respiratory tuberculosis, bacteriologically and histologically confirmed
A15.0 A15.0 A15.0 - Tuberculosis of lung, confirmed by sputum microscopy with or without culture
A15.1 A15.1 A15.1 - Tuberculosis of lung, confirmed by culture only
A15.2 A15.2 A15.2 - Tuberculosis of lung, confirmed histologically
A15.3 A15.3 A15.3 - Tuberculosis of lung, confirmed by unspecified means
A15.4 A15.4 A15.4 - Tuberculosis of intrathoracic lymph nodes, confirmed bacteriologically and histologically
A15.5 A15.5 A15.5 - Tuberculosis of larynx, trachea and bronchus, confirmed bacteriologically and histologically
A15.6 A15.6 A15.6 - Tuberculous pleurisy, confirmed bacteriologically and histologically
A15.7 A15.7 A15.7 - Primary respiratory tuberculosis, confirmed bacteriologically and histologically
A15.8 A15.8 A15.8 - Other respiratory tuberculosis, confirmed bacteriologically and histologically
A15.9 A15.9 A15.9 - Respiratory tuberculosis unspecified, confirmed bacteriologically and histologically
A16 A16 A16 - Respiratory tuberculosis, not confirmed bacteriologically or histologically
A16.0 A16.0 A16.0 - Tuberculosis of lung, bacteriologically and histologically negative
A16.1 A16.1 A16.1 - Tuberculosis of lung, bacteriological and histological examination not done
A16.2 A16.2 A16.2 - Tuberculosis of lung, without mention of bacteriological or histological confirmation
A16.3 A16.3 A16.3 - Tuberculosis of intrathoracic lymph nodes, without mention of bacteriological or histological confirmation
A16.4 A16.4 A16.4 - Tuberculosis of larynx, trachea and bronchus, without mention of bacteriological or histological confirmation
A16.5 A16.5 A16.5 - Tuberculous pleurisy, without mention of bacteriological or histological confirmation
A16.7 A16.7 A16.7 - Primary respiratory tuberculosis without mention of bacteriological or histological confirmation
A16.8 A16.8 A16.8 - Other respiratory tuberculosis, without mention of bacteriological or histological confirmation
A16.9 A16.9 A16.9 - Respiratory tuberculosis unspecified, without mention of bacteriological or histological confirmation
A17 A17 A17 - Tuberculosis of nervous system
A17.0 A17.0 A17.0 - Tuberculous meningitis
A17.1 A17.1 A17.1 - Meningeal tuberculoma
A17.8 A17.8 A17.8 - Other tuberculosis of nervous system
A17.9 A17.9 A17.9 - Tuberculosis of nervous system, unspecified
A18 A18 A18 - Tuberculosis of other organs
A18.0 A18.0 A18.0 - Tuberculosis of bones and joints
A18.1 A18.1 A18.1 - Tuberculosis of genitourinary system
A18.2 A18.2 A18.2 - Tuberculous peripheral lymphadenopathy
A18.3 A18.3 A18.3 - Tuberculosis of intestines, peritoneum and mesenteric glands
A18.4 A18.4 A18.4 - Tuberculosis of skin and subcutaneous tissue
A18.5 A18.5 A18.5 - Tuberculosis of eye
A18.6 A18.6 A18.6 - Tuberculosis of ear
A18.7 A18.7 A18.7 - Tuberculosis of adrenal glands
A18.8 A18.8 A18.8 - Tuberculosis of other specified organs
A19 A19 A19 - Miliary tuberculosis
A19.0 A19.0 A19.0 - Acute miliary tuberculosis of a single specified site
A19.1 A19.1 A19.1 - Acute miliary tuberculosis of multiple sites
A19.2 A19.2 A19.2 - Acute miliary tuberculosis, unspecified
A19.8 A19.8 A19.8 - Other miliary tuberculosis
A19.9 A19.9 A19.9 - Miliary tuberculosis, unspecified
unknown Unknown Unknown diagnosis
Code Display Definition
MDRnonXDR MDR non XDR Multidrug resistance: resistance to at least both isoniazid and rifampicin
monoDR Mono DR Monoresistance: resistance to one first-line anti-TB drug only
polyDR Poly DR Polydrug resistance: resistance to more than one first-line anti-TB drug (other than both isoniazid and rifampicin)
sensitive Sensitive No resistance to TB drugs
XDR XDR Extensive drug resistance: resistance to any fluoroquinolone and to at least one of three second-line injectable drugs (capreomycin, kanamycin and amikacin), in addition to multidrug resistance
Code Display Definition
DST DST Drug sensivity test
bactec Bactec Determination of drug susceptibility testing of Mycobacterium in an automated system BACTEC MGIT 960
hain FL-LPA First-line Drug Line Probe Assay
lpaOther SL-LPA Second-line Drug Line Probe Assay
le Lowenstein-Jensen Solid medium Lowenstein - Jensen containing drug concentration
genexpert GeneXpert Xpert MTB / RIF test to carry out the detection of the presence of Mycobacterium tuberculosis in a sample of diagnostic material and resistance to rifampicin in less than two hours
Code Display Definition
employed Employed Official work/position
retired Retired Retirement age (not working)
student Student Higher or secondary education in progress
unemployed Unemployed No official work/position
disabled Disabled Disability for medical reasons
selfEmployed Self-employed Self-employed
homemaker Homemaker Homemaker
Code Display Definition
less10mm Less than 10mm Lung cavity size less than 10mm
10-25mm 10-25mm Lung cavity size less than 10-25mm
more25mm More than 25mm Lung cavity size more than 25mm
no No cavities No lung cavity
Code Display Definition
zn Ziehl-Neelsen Ziehl-Neelsen
florescence Fluorescence Fluorescence
notSpecified Not Specified Not Specified
Code Display Definition
rightLung Right lung Affect localized in right lung
leftLung Left lung Affect localized in left lung
both Both lungs Affect localized in both lungs
Code Display Definition
less2 Less than 2 segments Prevalence of process in less than 2 segments
more2 2 or more segments Prevalence of process in more than or equal to 2 segments
Code Display Definition
homeless Homeless Patient does not have a permanent place of residence and / or registration
exPrisoner Ex prisoner The patient was imprisoned in the past
travelOutOfWork Worked abroad Country citizen, spent some time working abroad
tbFacility TB care worker Patient works in the health system (TB facility or general healthcare)
tobacoUse Current smoker Current smoker
drugAbuse Patient drug abuse Patient drug abuse
alcoholism Patient alcohol abuse Patient alcohol abuse
ContactOfKnownMdrTbCase Documented MDR contact Contact with MDR was investigated and documented
Code Display Definition
1 1 cavity One lung cavity
2 2 cavities Two lung cavities
more3 More than 2 cavities More than two cavities
no No cavities No cavities